insights_auto
Why is CUV down 2.88%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.42
arrow_downward
-2.88%(-0.22) 1D
Nov 13, 4:10:12 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
0.00
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.55
High
A$7.57
Low
A$7.34
Mkt. cap
374.61M
Avg. vol.
157.39K
Volume
0.00
Dividend
0.67%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.11
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
Benzinga
·
58 minutes ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
BigGo Finance
·
8 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
5 hours ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com